MoneyWorks4Me

The company witnessed a 12.41% growth in the revenue at Rs. 27350.00 millions for the quarter ended March 2026 as compared to Rs. 24330.00 millions during the year-ago period.The Net proft of the company remain more or less same to Rs. 4670.00  millions from Rs. 4740.00 millions ,decline by -1.48%.OP of the company witnessed a marginal growth to 10610.00 millions from 8830.00 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202603 202503 % Var 202603 202503 % Var 202603 202503 % Var
Sales 27350.00 24330.00 12.41 107120.00 96820.00 10.64 107120.00 96820.00 10.64
Other Income 580.00 150.00 286.67 180.00 320.00 -43.75 180.00 320.00 -43.75
PBIDT 10610.00 8830.00 20.16 40720.00 36070.00 12.89 40720.00 36070.00 12.89
Interest 2250.00 470.00 378.72 3410.00 2130.00 60.09 3410.00 2130.00 60.09
PBDT 7890.00 8120.00 -2.83 36610.00 33700.00 8.64 36610.00 33700.00 8.64
Depreciation 1970.00 1900.00 3.68 7640.00 7600.00 0.53 7640.00 7600.00 0.53
PBT 5920.00 6220.00 -4.82 28970.00 26100.00 11.00 28970.00 26100.00 11.00
TAX 1250.00 1480.00 -15.54 7050.00 7220.00 -2.35 7050.00 7220.00 -2.35
Deferred Tax 530.00 -120.00 -541.67 -150.00 1810.00 -108.29 -150.00 1810.00 -108.29
PAT 4670.00 4740.00 -1.48 21920.00 18880.00 16.10 21920.00 18880.00 16.10
Equity 1692.30 1692.30 0.00 1692.30 1692.30 0.00 1692.30 1692.30 0.00
PBIDTM(%) 38.79 36.29 6.89 38.01 37.25 2.04 38.01 37.25 2.04
Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..